From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.7, 2011-07, pp. : 1015-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ENMD-2076 for hematological malignancies

By How Jonathan Yee Karen

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 717-732

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonate Therapy in the Treatment of Multiple Myeloma

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-01 ,pp. : 3028-3036

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapy in multiple myeloma

By Avilés Agustin Neri Natividad Nambo M. Cleto Sergio Castañeda Claudia González Martha Talavera Alejandra Huerta-Guzmán Judith

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 411-415

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy for Multiple Myeloma

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 247-255

Bentham Science Publishers

Access to resources Recommend Favorite

Results of the first bortezomib-based induction therapy in the treatment of multiple myeloma

By Kortüüm Martin Einsele Hermann

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1661-1663

Informa Healthcare

Access to resources Recommend Favorite